XML 42 R33.htm IDEA: XBRL DOCUMENT

Segment information (Tables)

3 Months Ended

Mar. 31, 2021

The segment operating results of the reportable segments for the three months ended March 31, 2021 is disclosed as follows:

	Three months ended March 31, 2021
	Rental Operations			In-Patient services			Total

Revenue	$	90,793		$	—		$	90,793
Operating expenditure		(32,849	)		(19,167	)		(52,016	)

Operating income (loss)		57,944			(19,167	)		38,777

Other (expense) income
Loss on debt conversion		—			(1,106,648	)		(1,106,648	)
Penalty on convertible notes		—			(9,240	)		(9,240	)
Fair value of warrants granted					(976,788	)		(976,788	)
Fair value of warrants exercised					(90,000	)		(90,000	)
Interest expense		(59,745	)		(77,932	)		(137,677	)
Amortization of debt discount		—			(502,677	)		(502,677	)
Change in fair value of derivative liability		—			495,589			495,589
Foreign exchange movements		(18,695	)		(60,797	)		(79,492	)
Net loss before taxation		(20,496	)		(2,347,660	)		(2,368,156	)
Taxation		—			—			—
Net loss	$	(20,496	)	$	(2,347,660	)	$	(2,368,156	)

The operating assets and liabilities of the reportable segments as of March 31, 2021 is as follows:

	March 31, 2021
	Rental Operations			In-Patient services			Total

Purchase of fixed assets	$	—		$	—		$	—
Assets
Current assets		4,580			1,196,939			1,201,519
Non-current assets		2,885,861			5,157			2,891,018
Liabilities
Current liabilities		(1,484,968	)		(12,388,857	)		(13,873,825	)
Non-current liabilities		(4,645,209	)		—			(4,645,209	)
Mandatory redeemable preferred shares		—			(400,000	)		(400,000	)
Intercompany balances		1,330,423			(1,330,423	)		—
Net liability position	$	(1,909,313	)	$	(12,917,184	)	$	(14,826,497	)

ETHEMA HEALTH CORPORATION

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

16.

Segment information (continued)

The segment operating results of the reportable segments for the three months ended March 31, 2020 is disclosed as follows:

	Three months ended March 31, 2020
	Rental Operations			In-Patient services			Total
Revenue	$	83,542		$	-		$	83,542
Operating expenditure		30,300			143,849			174,149

Operating income (loss)		53,242			(143,849	)		(90,607	)

Other (expense) income
Other income
Loss on conversion of convertible notes		-			(286,343	)		(286,343	)
Exercise of warrants		-			(92,952	)		(92,952	)
Interest income		-			60			60
Interest expense		(61,398	)		(132,524	)		(193,922	)
Amortization of debt discount		-			(403,677	)		(403,677	)
Change in fair value of derivative liability		-			(9,754,896	)		(9,754,896	)
Foreign exchange movements		71,619			412,432			484,051
Net income (loss) before taxation		63,463			(10,401,749	)		(10,338,286	)
Taxation		-			-			-
Net income (loss)	$	63,463		$	(10,401,749	)	$	(10,338,286	)

The operating assets and liabilities of the reportable segments as of March 31, 2020 is as follows: